Incidence and Clinical Implications of Placenta Accreta Spectrum after Treatment for Asherman Syndrome

被引:8
|
作者
Tavcar, Jovana [1 ,3 ,4 ]
Movilla, Peter [1 ]
Carusi, Daniela A. [2 ]
Loring, Megan [1 ]
Reddy, Himabindu [2 ]
Isaacson, Keith [1 ]
Morris, Stephanie N. [1 ]
机构
[1] Mass Gen Brigham, Newton Wellesley Hosp, Ctr Minimally Invas Gynecol Surg, Newton, MA USA
[2] Mass Gen Brigham, Brigham & Womens Hosp, Dept Obstet & Gynecol, Boston, MA USA
[3] Medstar Georgetown Univ Hosp, Washington, DC USA
[4] Medstar Georgetown Univ Hosp, 3800 Reservoir Rd, Washington, DC 20007 USA
关键词
Abnormal placentation; Hysteroscopy; Intrauterine adhesions; ABNORMALLY INVASIVE PLACENTA; CONSERVATIVE MANAGEMENT; ADHERENT PLACENTA; MORBIDITY; OUTCOMES; PREVIA;
D O I
10.1016/j.jmig.2022.11.013
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Study Objective: To investigate the incidence, predictors, and clinical implications of placenta accreta spectrum (PAS) in pregnancies after hysteroscopic treatment for Asherman syndrome (AS).Design: This is a retrospective cohort study, conducted through a telephone survey and chart review.Setting: Minimally invasive gynecologic surgery center in an academic community hospital.Patients: Database of 355 patients hysteroscopically treated for AS over 4 years. We identified patients who achieved preg-nancy past the first trimester and evaluated the incidence and predictors for PAS as well as associated clinical implications.Interventions: Telephone survey.Measurements and Main Results: We identified 97 patients meeting the inclusion criteria. Among these patients, 23 (23.7%) patients had PAS. History of cesarean delivery was the only variable statistically significantly associated with having PAS (adjusted odds ratio 4.03, 95% confidence interval 1.31-12.39). PAS was diagnosed antenatally in 3 patients (14.3%), with patients having placenta previa more likely to be diagnosed (p <.01). Nine patients (39.13%) with PAS required cesarean hysterectomy, which is 9.3% of those with a pregnancy that progressed past the first trimester. Factors associated with cesarean hysterectomy were the eti-ology of AS (dilation and evacuation after the second trimester pregnancy or postpartum instrumentation, p <.01), invasive placenta (increta or percreta, p <.05), and history of morbidly adherent placenta in previous pregnancies (p <.05). Two patients with PAS (9.5%) had uterine rupture, and another 2 (9.5%) experienced uterine inversion.Conclusion: There is a high incidence of PAS and associated morbidity in pregnancies after hysteroscopic treatment for AS. There is a low rate of antenatal diagnosis as well as a lack of reliable clinical predictors, which both stress the importance of clinical awareness, careful counseling, and delivery planning. Journal of Minimally Invasive Gynecology (2023) 30, 192 -198.(c) 2022 AAGL. All rights reserved.
引用
收藏
页码:192 / 198
页数:7
相关论文
共 50 条
  • [1] Placenta accreta: adherent placenta due to Asherman syndrome
    Engelbrechtsen, Line
    Langhoff-Roos, Jens
    Kjer, Jens Joergen
    Istre, Olav
    CLINICAL CASE REPORTS, 2015, 3 (03): : 175 - 178
  • [2] Placenta Accreta An Association With Fibroids and Asherman Syndrome
    Al-Serehi, Amal
    Mhoyan, Anna
    Brown, Michelle
    Benirschke, Kurt
    Hull, Andrew
    Pretorius, Dolores H.
    JOURNAL OF ULTRASOUND IN MEDICINE, 2008, 27 (11) : 1623 - 1628
  • [3] Detection of Asherman's syndrome after conservative management of placenta accreta: A case report
    Chikazawa K.
    Imai K.
    Liangcheng W.
    Sasaki S.
    Horiuchi I.
    Kuwata T.
    Takagi K.
    Journal of Medical Case Reports, 12 (1)
  • [4] Treatment modalities for placenta accreta spectrum
    Lucas, Nuala
    Rex, Steffen
    Devroe, Sarah
    LANCET, 2024, 403 (10425): : 437 - 437
  • [5] Asherman's syndrome after removal of placenta remnants: a serious clinical problem
    Hooker, A. B.
    Thurkow, A.
    GYNECOLOGICAL SURGERY, 2011, 8 (04) : 449 - 453
  • [6] Clinical factors associated with a placenta accreta spectrum
    Imafuku, Hitomi
    Tanimura, Kenji
    Shi, Yutoku
    Uchida, Akiko
    Deguchi, Masashi
    Terai, Yoshito
    PLACENTA, 2021, 112 : 180 - 184
  • [7] Placenta membranacea with placenta accreta: radiologic diagnosis and clinical implications
    Pereira, Nigel
    Yao, Ruofan
    Guilfoil, Daniel S.
    Richard, Scott D.
    Plante, Lauren A.
    PRENATAL DIAGNOSIS, 2013, 33 (13) : 1293 - 1296
  • [8] Placenta accreta spectrum: ultrasound diagnosis and clinical correlation
    Tsankova, Mariana
    Kirkova, Mila
    Geshev, Nikolay
    BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT, 2023, 37 (01)
  • [9] Outcomes of Subsequent Births After Placenta Accreta Spectrum
    Baldwin, Heather J.
    Nippita, Tanya A.
    Torvaldsen, Siranda
    Ibiebele, Ibinabo
    Ford, Jane B.
    Patterson, Jillian A.
    OBSTETRICS AND GYNECOLOGY, 2020, 136 (04): : 745 - 755
  • [10] Telemedicine as a strategy to facilitate placenta accreta spectrum treatment
    Nieto-Calvache, Albaro Jose
    Nieto-Calvache, Alejandro Solo
    Aguilera, Lorgio Rudy
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2022, 35 (25): : 8284 - 8285